Fit Story
Accommodating TerSera Therapeutics’
Healthy Growth
CLIENT PROFILE
- Pharmaceutical company dedicated to delivering better outcomes for patients
- High growth company headquartered in Illinois
PERFECT FIT CRITERIA
- Upscale office space to complement the firm’s growth goals
- Fully funded tenant improvement on Five-year lease
- High end amenities
The Challenge
TerSera Therapeutics is a high growth pharmaceutical company that acquires and develops specialty pharmaceutical products and intelligent solutions to serve patients partners and prescribers. To accommodate its next phase of growth, TerSera required a Class A building with premium amenities. It was imperative to maximize a tight budget while securing a five-year lease with fully funded tenant improvements. The high end tenant improvements that TerSera preferred are more typical for a 10-year lease.
The Solution
To reach an agreement, we identified an opportunity to partner with a design build firm, Arco Murray. The budget was sufficient for us to negotiate with the landlord to fully fund the construction and project management. We recommended a furniture vendor, Office Revolution, which streamlined and expedited the process. This helped TerSera ensure control over the finished look and feel of the space – all the way down to the art on the walls.
The Outcome
We negotiated an above-market tenant improvement package while avoiding a long-term lease commitment. The high end space is designed with a large town hall space, multiple collaboration areas, and many technology driven conference rooms. “Our new location is a significant expansion in terms of space and amenities, and has thrilled and invigorated our entire team,” says Edward J. Fiorentino, TerSera’s Chairman and CEO.
“Our new location is a significant expansion in terms of space and amenities and has thrilled and invigorated our entire team. Bespoke did an exceptional job in all aspects of our move, from new lease negotiation to exiting the old lease to bringing external vendors to the table that provided an outstanding service.”
Edward J. Fiorentino
Chairman and CEO, TerSera Therapeutics